StockData
Hyperfine, Inc. logo

Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.56−0.05 (-7.95%)

Close on Nov 17, 2026Market cap $59.56MP/E –Yield –

Hyperfine operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Hyperfine's operating cash flow for the twelve months ending Jun 30, 2026 was -$27.07M. For fiscal 2025 it was -$27.95M. The highest annual figure on record is -$21.53M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$27.95M–
FY2024Dec 31, 2024-$38.77M–
FY2023Dec 31, 2023-$41.81M–
FY2022Dec 31, 2022-$72.34M–
FY2021Dec 31, 2021-$47.18M–
FY2020Dec 31, 2020-$21.53M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.27M–
Q1 FY2026Mar 31, 2026-$9.01M–
Q4 FY2025Dec 31, 2025-$5.21M–
Q3 FY2025Sep 30, 2025-$5.58M–
Q2 FY2025Jun 30, 2025-$7.91M–
Q1 FY2025Mar 31, 2025-$9.25M–
Q4 FY2024Dec 31, 2024-$8.36M–
Q3 FY2024Sep 30, 2024-$8.52M–
Q2 FY2024Jun 30, 2024-$9.38M–
Q1 FY2024Mar 31, 2024-$12.51M–
Q4 FY2023Dec 31, 2023-$9.94M–
Q3 FY2023Sep 30, 2023-$8.72M–
Q2 FY2023Jun 30, 2023-$9.66M–
Q1 FY2023Mar 31, 2023-$13.49M–
Q4 FY2022Dec 31, 2022-$15.35M–
Q3 FY2022Sep 30, 2022-$12.79M–
Q2 FY2022Jun 30, 2022-$16.91M–
Q1 FY2022Mar 31, 2022-$27.29M–
Q4 FY2021Dec 31, 2021-$18.14M–
Q3 FY2021Sep 30, 2021-$9.94M–
Q2 FY2021Jun 30, 2021-$11.62M–
Q1 FY2021Mar 31, 2021-$7.49M–

More Hyperfine figures

See a number that looks wrong?